Numark Migraine Relief (Sumatriptan)

Sumatriptan works by selectively stimulating serotonin 5‑HT1B and 5‑HT1D receptors in the brain. This action causes constriction of dilated intracranial blood vessels and blocks the release of inflammatory neuropeptides, interrupting the migraine cascade and providing rapid symptom relief.

The appropriate dose is determined by a qualified prescriber based on the patient’s clinical condition, prior response, and tolerability. Common oral tablet strengths range from 25 mg to 100 mg, but the exact regimen should be individualized and instructed by a healthcare professional.

Safety data for sumatriptan in pregnancy and lactation are limited. It should only be used when the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details and any required import documentation.

Numark Migraine Relief (sumatriptan) belongs to the triptan class, which is more migraine‑specific than non‑steroidal anti‑inflammatory drugs (NSAIDs). Compared with other triptans, sumatriptan has a well‑established efficacy profile and is available in multiple oral strengths, offering flexibility for individual patient needs.

Store the tablets at room temperature, below 25 °C, in the original packaging. Keep the product away from moisture, heat and direct sunlight. Do not refrigerate or freeze the tablets, as this may affect their stability and potency.

Numark Migraine Relief is taken orally as a tablet. The tablet should be swallowed whole with a glass of water, preferably at the first sign of a migraine attack. Do not crush, chew, or split the tablet unless specifically instructed by a healthcare provider.

The most serious risks include coronary vasospasm, which can lead to chest pain or myocardial infarction, and serotonin syndrome when combined with other serotonergic drugs. Patients should be monitored for severe chest discomfort, rapid heart rate, high fever, agitation, or muscle rigidity, and seek immediate medical attention if these occur.

Numark Migraine Relief should be avoided in individuals with uncontrolled hypertension, a history of ischemic heart disease, recent myocardial infarction, stroke, peripheral vascular disease, or known hypersensitivity to sumatriptan or any excipients. It is also contraindicated in patients taking MAO inhibitors or other triptans.